[Ref.: #8482]
Sample type/isolated from
intestine of infant
[Ref.: #67770]
Sample type/isolated from
Intestine of infant
* marker position based on {}
Isolation sources categories
#Host
#Human
#Child
#Host Body-Site
#Gastrointestinal tract
-
Information on genomic background e.g. entries in nucleic sequence databass Sequence information
16S Sequence information:
Only first 5 entries are displayed. Click here to see all. Click here to see only first 5 entries.
Sequence accession description
Seq. accession number
Sequence length (bp)
Sequence database
Associated NCBI tax ID
[Ref.: #20218]
Bifidobacterium breve gene for 16S rRNA, partial sequence, strain: ATCC 15700
AB006658
1520
518634 tax ID
*
[Ref.: #20218]
Bifidobacterium breve partial 16S rRNA gene, type strain ATCC 15700T
AM411121
179
518634 tax ID
*
[Ref.: #20218]
Bifidobacterium breve 16S ribosomal RNA
M58731
1536
1685 tax ID
*
[Ref.: #20218]
Bifodibacterium breve (ATCC 15700) 16S ribosomal RNA gene, partial
M84776
642
1685 tax ID
*
[Ref.: #20218]
Bifidobacterium breve strain DSM 20213 16S ribosomal RNA gene, partial sequence
HQ012023
939
518634 tax ID
*
[Ref.: #20218]
Bifidobacterium breve gene for 16S rRNA, partial sequence, strain: JCM 1192
AB116288
479
518634 tax ID
*
[Ref.: #20218]
Bifidobacterium breve gene for 16S rRNA, partial sequence, strain: JCM 1192
AB507084
672
518634 tax ID
*
[Ref.: #20218]
Bifidobacterium breve strain KCTC 3220 16S ribosomal RNA gene, partial sequence
GU361815
1483
1685 tax ID
*
[Ref.: #67770]
Bifidobacterium breve gene for 16S ribosomal RNA, partial sequence, strain: JCM 1192
LC071793
1418
518634 tax ID
Availability in culture collections External links
[Ref.: #8482]
Culture collection no.
DSM 20213 , ATCC 15700 , NCTC 11815 , JCM 1192 , BCRC 11846 , CCUG 18365 , CCUG 30511 , CECT 4839 , CGMCC 1.2213 , CIP 64.69 , KCTC 3220 , LMG 10501 , LMG 11042 , NCFB 2257
[Ref.: #20218]
Associated Passport(s) in StrainInfo
5433 , 5426 , 5438
Literature:
Only first 10 entries are displayed. Click here to see all. Click here to see only first 10 entries.
Topic
Title
Authors
Journal
DOI
Year
Pathogenicity
Growth characteristics of bifidobacteria in infant formulas.
Dubey UK, Mistry VV
J Dairy Sci
10.3168/jds.S0022-0302(96)76468-8
1996
*
Pathogenicity
Effect of bifidogenic factors on growth characteristics of bifidobacteria in infant formulas.
Dubey UK, Mistry VV
J Dairy Sci
10.3168/jds.S0022-0302(96)76469-X
1996
*
Metabolism
Involvement of trihydroxyconjugated bile salts in cholesterol assimilation by bifidobacteria.
Tahri K, Grill JP, Schneider F
Curr Microbiol
10.1007/s002849900148
1997
*
Cultivation
Effects of fructooligosaccharides and their monomeric components on bile salt resistance in three species of bifidobacteria.
Perrin S, Grill JP, Schneider F
J Appl Microbiol
10.1046/j.1365-2672.2000.01070.x
2000
*
Metabolism
The effect of nisin on the physiology of Bifidobacterium thermophilum.
Kot E, Murad Y, Bezkorovainy A
J Food Prot
10.4315/0362-028x-64.8.1206
2001
*
Metabolism
Cholic acid accumulation and its diminution by short-chain fatty acids in bifidobacteria.
Kurdi P, Tanaka H, van Veen HW, Asano K, Tomita F, Yokota A
Microbiology (Reading)
10.1099/mic.0.26376-0
2003
*
Metabolism
Growth-promoting effects of lactoferrin on L. acidophilus and Bifidobacterium spp.
Kim WS, Ohashi M, Tanaka T, Kumura H, Kim GY, Kwon IK, Goh JS, Shimazaki K
Biometals
10.1023/b:biom.0000027705.57430.f1
2004
*
Phylogeny
Modulation of rat cecal microbiota by administration of raffinose and encapsulated Bifidobacterium breve.
Dinoto A, Suksomcheep A, Ishizuka S, Kimura H, Hanada S, Kamagata Y, Asano K, Tomita F, Yokota A
Appl Environ Microbiol
10.1128/AEM.72.1.784-792.2006
2006
*
Pathogenicity
Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria.
Kurdi P, Kawanishi K, Mizutani K, Yokota A
J Bacteriol
10.1128/JB.188.5.1979-1986.2006
2006
*
Pathogenicity
Yoghurt fermented by Lactobacillus delbrueckii subsp. bulgaricus H+ -ATPase-defective mutants exhibits enhanced viability of Bifidobacterium breve during storage.
Ongol MP, Sawatari Y, Ebina Y, Sone T, Tanaka M, Tomita F, Yokota A, Asano K
Int J Food Microbiol
10.1016/j.ijfoodmicro.2007.02.019
2007
*
Pathogenicity
Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.
Matsumoto T, Ishikawa H, Tateda K, Yaeshima T, Ishibashi N, Yamaguchi K
J Appl Microbiol
10.1111/j.1365-2672.2007.03593.x
2007
*
Pathogenicity
Synbiotic promotion of epithelial proliferation by orally ingested encapsulated Bifidobacterium breve and raffinose in the small intestine of rats.
Ishizuka S, Iwama A, Dinoto A, Suksomcheep A, Maeta K, Kasai T, Hara H, Yokota A
Mol Nutr Food Res
10.1002/mnfr.200800041
2009
*
Metabolism
In vitro fermentation of arabinoxylan-derived carbohydrates by bifidobacteria and mixed fecal microbiota.
Pastell H, Westermann P, Meyer AS, Tuomainen P, Tenkanen M
J Agric Food Chem
10.1021/jf901397b
2009
*
Pathogenicity
The influence of some probiotic supernatants on the growth and virulence features expression of several selected enteroaggregative E. coli clinical strains.
Lazar V, Miyazaki Y, Hanawa T, Chifiriuc MC, Ditu LM, Marutescu L, Bleotu C, Kamiya S
Roum Arch Microbiol Immunol
2009
*
Metabolism
Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria.
Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J, Kitaoka M
J Biol Chem
10.1074/jbc.M111.248138
2011
*
Metabolism
Characterization of a Panela cheese with added probiotics and fava bean starch.
Escobar MC, Van Tassell ML, Martinez-Bustos F, Singh M, Castano-Tostado E, Amaya-Llano SL, Miller MJ
J Dairy Sci
10.3168/jds.2011-4655
2012
*
Pathogenicity
Identification and accurate quantitation of biological oligosaccharide mixtures.
Strum JS, Kim J, Wu S, De Leoz ML, Peacock K, Grimm R, German JB, Mills DA, Lebrilla CB
Anal Chem
10.1021/ac301128s
2012
*
Phylogeny
Isolation of a bifidogenic peptide from the pepsin hydrolysate of bovine lactoferrin.
Oda H, Wakabayashi H, Yamauchi K, Sato T, Xiao JZ, Abe F, Iwatsuki K
Appl Environ Microbiol
10.1128/AEM.03343-12
2013
*
Metabolism
Two beta-galactosidases from the human isolate Bifidobacterium breve DSM 20213: molecular cloning and expression, biochemical characterization and synthesis of galacto-oligosaccharides.
Arreola SL, Intanon M, Suljic J, Kittl R, Pham NH, Kosma P, Haltrich D, Nguyen TH
PLoS One
10.1371/journal.pone.0104056
2014
*
Pathogenicity
RNA of Enterococcus faecalis Strain EC-12 Is a Major Component Inducing Interleukin-12 Production from Human Monocytic Cells.
Nishibayashi R, Inoue R, Harada Y, Watanabe T, Makioka Y, Ushida K
PLoS One
10.1371/journal.pone.0129806
2015
*
Genetics
Complete genome sequence of Bifidobacterium breve JCM 1192(T) isolated from infant feces.
Morita H, Toh H, Oshima K, Nakano A, Omori E, Hattori Y, Arakawa K, Suda W, Honda K, Hattori M
J Biotechnol
10.1016/j.jbiotec.2015.06.414
2015
*
Pathogenicity
Interaction of mouse splenocytes and macrophages with bacterial strains in vitro: the effect of age in the immune response.
Van Beek AA, Hoogerland JA, Belzer C, De Vos P, De Vos WM, Savelkoul HF, Leenen PJ
Benef Microbes
10.3920/BM2015.0094
2015
*
Enzymology
In vitro and in vivo evaluation of the prebiotic effect of raw and roasted almonds (Prunus amygdalus).
Liu Z, Wang W, Huang G, Zhang W, Ni L
J Sci Food Agric
10.1002/jsfa.7604
2016
*
Metabolism
Mechanistic Study of Utilization of Water-Insoluble Saccharomyces cerevisiae Glucans by Bifidobacterium breve Strain JCM1192.
Keung HY, Li TK, Sham LT, Cheung MK, Cheung PCK, Kwan HS
Appl Environ Microbiol
10.1128/AEM.03442-16
2017
*
Metabolism
Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli.
Thongaram T, Hoeflinger JL, Chow J, Miller MJ
J Dairy Sci
10.3168/jds.2017-12753
2017
*
Phylogeny
Bifidobacterium callitrichidarum sp. nov. from the faeces of the emperor tamarin (Saguinus imperator).
Modesto M, Michelini S, Sansosti MC, De Filippo C, Cavalieri D, Qvirist L, Andlid T, Spiezio C, Sandri C, Pascarelli S, Sgorbati B, Mattarelli P
Int J Syst Evol Microbiol
10.1099/ijsem.0.002472
2017
*
Enzymology
Highly Selective Production of Compound K from Ginsenoside Rd by Hydrolyzing Glucose at C-3 Glycoside Using beta-Glucosidase of Bifidobacterium breve ATCC 15700.
Zhang R, Huang XM, Yan HJ, Liu XY, Zhou Q, Luo ZY, Tan XN, Zhang BL
J Microbiol Biotechnol
10.4014/jmb.1808.08059
2019
*
Metabolism
Linoleic acid induces metabolic stress in the intestinal microorganism Bifidobacterium breve DSM 20213.
Senizza A, Rocchetti G, Callegari ML, Lucini L, Morelli L
Sci Rep
10.1038/s41598-020-62897-w
2020
*
Biotechnology
Impact of prebiotics on equol production from soymilk isoflavones by two Bifidobacterium species.
Mustafa SE, Mustafa S, Ismail A, Abas F, Abd Manap MY, Ahmed Hamdi OA, Elzen S, Nahar L, Sarker SD
Heliyon
10.1016/j.heliyon.2020.e05298
2020
*
Pathogenicity
Safety Evaluation of Bifidobacterium breve IDCC4401 Isolated from Infant Feces for Use as a Commercial Probiotic.
Choi IY, Kim J, Kim SH, Ban OH, Yang J, Park MK
J Microbiol Biotechnol
10.4014/jmb.2103.03041
2021
*
Phylogeny
Comparison of 16S rRNA Gene Based Microbial Profiling Using Five Next-Generation Sequencers and Various Primers.
Park C, Kim SB, Choi SH, Kim S
Front Microbiol
10.3389/fmicb.2021.715500
2021
*
A Novel Lactobacillus casei LP1 Producing 1,4-Dihydroxy-2-Naphthoic Acid, a Bifidogenic Growth Stimulator.
Kang JE, Kim TJ, Moon GS
Prev Nutr Food Sci
10.3746/pnf.2015.20.1.78
2015
*
Supplementation with Lactobacillus plantarum WCFS1 Prevents Decline of Mucus Barrier in Colon of Accelerated Aging Ercc1(-/Delta7) Mice.
van Beek AA, Sovran B, Hugenholtz F, Meijer B, Hoogerland JA, Mihailova V, van der Ploeg C, Belzer C, Boekschoten MV, Hoeijmakers JH, Vermeij WP, de Vos P, Wells JM, Leenen PJ, Nicoletti C, Hendriks RW, Savelkoul HF
Front Immunol
10.3389/fimmu.2016.00408
2016
*
Effects of Linoleic Acid on Gut-Derived Bifidobacterium breve DSM 20213: A Transcriptomic Approach.
Senizza A, Callegari ML, Senizza B, Minuti A, Rocchetti G, Morelli L, Patrone V
Microorganisms
10.3390/microorganisms7120710
2019
*
Evaluation of Bifidobacteria and Lactobacillus Probiotics as Alternative Therapy for Salmonella typhimurium Infection in Broiler Chickens.
El-Sharkawy H, Tahoun A, Rizk AM, Suzuki T, Elmonir W, Nassef E, Shukry M, Germoush MO, Farrag F, Bin-Jumah M, Mahmoud AM
Animals (Basel)
10.3390/ani10061023
2020
*
References
#8482
Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ;
DSM 20213
#42088
; Curators of the CIP;
#66794
Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg:
BRENDA, the ELIXIR core data resource in 2021: new developments and updates.
Nucleic Acids Res. 49:
D498 - D508
2020 (
DOI 10.1093/nar/gkaa1025 , PubMed 33211880 )
#67770
Japan Collection of Microorganism (JCM) ; Curators of the JCM;
#68371
Automatically annotated from API 50CH acid .
#69479
João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.:
MicrobeAtlas 1.0 beta
.
* These data were automatically processed and therefore are not curated
Change proposal
Successfully sent
Please take the time to answer our:
Survey